CrissmanJ.D., ZarboR.J., MaC.K.: Histopatologic parameters and DNA analysis in colorectal adenocarcinomas 24.Pathol. Annu., 24: 103–147, 1989.
2.
FischerD.S.Follow-up of cancer.Lippincott-Raven, Philadelphia-New York, 1996.
3.
GarettiW., DanovaM., GeidoE.: Flow cytometric DNA index in the prognosis of colorectal cancer.Cancer, 67: 1921–1927, 1991.
4.
HaskellC.M., LaveyR.S., RammingK.P.: Colon and rectum.In: Cancer treatment, HaskellC.M., 469–497, WB Saunders Co., Philadelphia, 1995.
5.
KernS.E., FearonE.R., TersmetteK.W.F.: Allelic loss in colorectal carcinoma.JAMA;261: 3099–3103, 1989.
6.
KokalW.A., GardineL.R., SheibaniK., MorrisP.L., PragerE., ZakI.W., TerzJ.J.: Tumor DNA content in resectable primary colorectal cancer.Ann. Surg., 209: 188–192, 1989.
7.
MelamedM.R., EnkerW.E., BannerP.: Flow cytometry of colorectal carcinoma with three-year follow-up.Dis. Colon Rectum, 29: 184–186, 1986.
8.
MizoguchiT., YamadaK., FurukawaT.: Expression of MDR 1 gene in human gastric and colorectal carcinomas.J. Natl. Cancer Inst., 82: 1679–1683, 1990.
9.
RognumT.O., ThorudE., LundE.: Survival of large bowel carcinoma patients with different DNA ploidy.Br. J. Cancer, 56: 633–636, 1987.
10.
ScottN., SagarP., StewartJ.: p53 in colorectal cancer: clinicopathological correlation and prognostic significance.Br. J. Cancer, 63: 317–319, 1991.
11.
SchillaciA., TirindelliD.D., FreeiM.: Flow cytometric analysis in colorectal carcinoma: prognostic significance of cellular DNA content.Int. J. Colorectal Dis.5: 223–227, 1990.
12.
WiggersT., ArendsJ.W., SchutteB.: A multivariate analysis of pathologic prognostic indicators in large bowel cancer.Cancer,61: 386–395, 1988.
13.
WitzigT.E., LoprinziC.L., GonchoroggN.J.: DNA polidy and cell kinetics measurements as predictors of recurrence and survival in stage B2 and colorectal adenocarcinoma.Cancer, 68: 879–888, 1991.
